| __timestamp | ACADIA Pharmaceuticals Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 129764000 |
| Thursday, January 1, 2015 | 76369000 | 152008000 |
| Friday, January 1, 2016 | 4406000 | 209620000 |
| Sunday, January 1, 2017 | 13060000 | 241786000 |
| Monday, January 1, 2018 | 18330000 | 315264000 |
| Tuesday, January 1, 2019 | 19598000 | 359466000 |
| Wednesday, January 1, 2020 | 20550000 | 524272000 |
| Friday, January 1, 2021 | 19141000 | 470515000 |
| Saturday, January 1, 2022 | 10166000 | 483669000 |
| Sunday, January 1, 2023 | 45731000 | 577065000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. This analysis delves into the cost of revenue trends for BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc. from 2014 to 2023. Over this period, BioMarin consistently outpaced ACADIA, with its cost of revenue peaking at approximately 578 million in 2023, a staggering 900% increase from 2014. In contrast, ACADIA's cost of revenue fluctuated, reaching its highest in 2015 but then declining by 40% by 2022. This disparity highlights BioMarin's robust growth and operational efficiency, while ACADIA's variable costs suggest a more volatile financial strategy. Understanding these trends is crucial for investors and stakeholders aiming to make informed decisions in the pharmaceutical sector.
Cost Insights: Breaking Down Johnson & Johnson and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BeiGene, Ltd. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs PTC Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Galapagos NV
BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: ACADIA Pharmaceuticals Inc. vs Dyne Therapeutics, Inc.